Given that the status of the p53 pathway is a critical determinant of bladder cancer prognosis ( 15 , 16 , 18 ), this finding is highly significant.
← all excerpts
MDM4 promotes chemoresistance in bladder cancer by attenuating P53-mediated EMT.
1
—
—